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ANALYSIS OF PATIENTS WITH  
THE ADDITIONAL BMI-BASED 
CLASSIFICATION
Several patients in the studies were obese (in the 
Italian study the percentage of obese patients was > 
50%). As excessive loads on one’s foot structure can 
modify one’s gait pattern and foot-loading distribution, 
patients within each group of both studies were fur-
ther divided into below (B) and above (A) an obesity 
threshold of 31.3kg/m2; the threshold was increased 
slightly to account for the additional weight of equip-
ment and clothing. Group C in the Italian study 
(healthy controls) was not divided as all volunteers in 
the group were below the BMI threshold. ANOVAs (p 
< 0.05) with multiple comparisons based on post-hoc 
Holm-Bonferroni correction (critical p values adjusted 
accordingly) were repeated for each dataset (Italian 
and Brazilian) after each group was divided. Table S1 
shows main clinical and anthropometric data within 
each sub-group; Tables 2S and 3S show the results from 
the statistical analysis on the Italian study and the Bra-
zilian study respectively.
In both databases, no statistically significant differ-
ences were found either among (R1-R3)B or among 
(R1-R3)A. However, intra-group variability decreased, 
and some heel and forefoot trends were observed in the 
below-threshold groups. This suggests that R1B slightly 
differed from the more compromised groups, while 
(R1-R3)A were very similar to one another, regarding al-
most all parameters and foot regions. Interestingly, dif-
ferences were found between B-groups and A-groups 
in each dataset, and when compared to either C in the 
Italian study or to non-neuropathic patients in the Bra-
zilian study (R0). More specifically: 
a) in the Italian study, the following parameters 
were significantly altered: 
1. PP: R1B lower than C (total foot and heel) and R3A 
higher than C (midfoot); 
2. CA: (R1-R3)B smaller than C (all areas) and (R2-
R3)A wider than C (forefoot and toes); 
3. MF: all groups, but R1A lower than C (forefoot; 
(R2-R3)A also lower at heel and R1A also lower at 
toes);
4. PTI: all A-groups higher than C (midfoot and fore-
foot); 
5. v) CT: with respect to C, longer absolute, over-
all stance in R1A, and longer relative stance in all 
groups (heel and forefoot; R1B at forefoot only). 
b) In the Brazilian study, the majority of patients in 
R0, R1 and R2 belonged to the below-threshold group, 
with as low as three patients only in R2A. Anyway, some 
differences were observed in the following parameters:
6. PP: both R3A and R3B had higher PP than R0B 
at forefoot, also higher than the corresponding val-
ues in all other groups. The total foot PP was also 
higher for R3, but differences were only highlighted 
between R0B and R3B; 
7. CA: high variability was found in all groups; dif-
ferences (without statistical significance) were ob-
served for R2B (total foot smaller than R0A, heel 
smaller than R2A, midfoot smaller than R1A), and 
for R3B heel (smaller than R2A); 
8. MF: no linear trend was found among the groups; 
R1A only was lower than R0B. 
Besides data in the Tables, and since statistical signifi-
cance might have been limited by high variability and 
relatively small samples, some interesting trends, and 
even lack of trends, are shown in Figure S1 for CT, PP, 
and PTI at heel and forefoot. 
COMPARISON BETWEEN THE TWO STUDIES
The three neuropathic groups – i.e. all patients in each 
group, without further BMI-based split – from the Italian 
study were also compared with corresponding Brazilian 
groups using 30 two-way ANOVAs (p < 0.05). Factor A 
was the study (Italian or Brazilian) and Factor B was the 
neuropathic risk group (R1, R2, or R3). Results from the 
statistical analysis are reported in Table S4.
Corresponding statistical analysis on neuropathic 
subgroups classified as below- and above- BMI threshold 
delivered the results summarized in the following Table 
S5. Basically, the analysis seems to highlight greater 
similarities between corresponding groups of the two 
studies when BMI is taken into account. However, due 
to the reduced sample size, this results should be only 
considered as a suggestion for further investigations.
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Table S1
Groups, clinical variables and anthropometric features for patients within the Italian and the Brazilian study, without and with BMI-based clas-
sification (mean and SD, % mean)
C R0 R0A R0B R1 R1A R1B R2 R2A R2B R3 R3A R3B
Italian 
study
n 20 18 10 8 37 20 17 28 13 15
Sex (M/F) 5/15 8/10 7/3 1/7 17/20 7/13 10/7 17/11 8/5 9/6
Age (years) 67.1 
(9.8)
65.5 
(13.8)
63.5 
(12.8)
68.6 
(15.2)
70.0 
(11.1)
68.7 
(10.8)
71.9 
(11.5)
69.3 
(13.9)
68.6 
(15.5)
69.7 
(13.5)
BMI  
(kg/m2)
27.4 
(6.9)
32.8 
(19.8) C
37.2 
(13.2)
C,R1B,R2B,R3B
27.2 
(10.3)
R1A,R2A,R3A
32.6 
(22.0) C
37.5 
(15.5) 
C,R1B,R2B,R3B
26.9 
(12.4) 
R1A,R2A,R3A
32.1 
(20.3) C
37.2 
(14.6) 
C,R1B,R2B,R3B
27.7 
(11.9) 
R1A,R2A,R3A
Stance 
(ms)
822.5 
(7.1)
957.0 
(21.7)
934.3
(12.4) C
985.4 
(29.7)
940.8 
(36.7)
936.0 
(46.5)
946.5 
(21.9)
894.0 
(18.2)
834.7 
(14.0)
945.4 
(19.3)
Type of 
diabetes 
(1/2)
1/17 1/9 0/8 1/36 1/19 0/17 7/21 0/13 7/8
DNI 4.3 
(19.8)
R2,R3
4.1  
(18.0) 
R2A,R2B,R3A,R3B
4.6 
(21.3) R2A
5.6
(13.2) R1
5.6
(12.4)
R1A,R1B
5.5
(14.6) R1A
5.7
(15.0) R1
5.6
(18.9) R1A
5.7
(12.6) R1A
VPT 35 (21) 38 (17) 32 (26) 34 (21) 34 (20) 34 (22) 37 (22) 35 (31) 38 (15)
ABI 1.1 
(16.4)
1.1 
(17.5)
1.0 
(11.7)
1.1 
(17.7)
1.1 
(19.4)
1.1 
(16.1)
1.1 
(21.1)
1.0 
(23.1)
1.2 
(18.9)
YOD 18.8 
(62.2)
18.1 
(69.8)
19.8 
(54.8)
19.1 
(63.5)
20.7 
(64.2)
17.0 
(61.7)
25.6 
(61.2)
23 
(66.0)
27.5 
(59.7)
Brazilian 
study
n 58 15 43 29 8 21 30 3 27 17 8 9
Sex (M/F) 28/30 7/8 21/22 16/13 4/4 12/9 11/19 R3 0/3 11/16 14/3 R0,R2 5 / 3 9/0
Age (years) 57.2 
(11.4)
57.2 
(15.0)
57.3 
(9.9)
56.9 
(8.1)
55.4 
(9.6)
57.5  
(7.3)
58.6  
(9.9)
54.7  
(9.1)
59.0 
(10.0)
58.1  
(9.1)
58.1 
(10.7)
58.0 
(8.1)
BMI 
(kg/m2)
28.8 
(16.3)
34.5
(9.3)
26.8 
(11.9)
29.3 
(14.7)
34.8 
(11.5)
27.4 
(7.7)
27.6 
(13.0)
34.6 
(9.0)
26.8 
(10.1)
30.4 
(17.4)
34.9 
(10.9)
26.5 
(8.7)
Stance 
(ms)
696.4 
(46.8)
659.4 
(12.5)
709.3 
(52.9)
663.0 
(8.3)
669.4 
(7.2)
661.3 
(9.0)
660.4 
(7.5)
697.3 
(7.3)
655.8 
(7.5)
670.2 
(8.2)
676.4 
(6.1)
670.3 
(10.3)
Type of 
diabetes 
(1/2)
0 / 58 0 / 15 0 / 43 0 / 29 0 / 8 0 / 21 0 / 30 0 / 3 0 / 27 0 / 17 0 / 8 0 / 9
NSS 3.7 
(102.7)
4.6 
(84.8)
3.3 
(112.1)
7.6 
(34.2) R0
5.4 
(61.1)
8.5 
(20.0)
7.3 
(34.2) R0
9.3 
(6.5)
7.0 
(37.1)
7.7 
(27.3) R0
8.1 
(19.8)
7.3 
(34.2)
HbA1c (%) 7.8 
(17.9)
8.0 
(10.0)
7.6 
(23.7)
8.8 
(13.6)
9.4 
(8.5)
8.1 
(14.8)
8.5 
(30.6)
10.9 
(43.1)
8.1 
(25.9)
8.3 
(34.9)
6.2 10.3
YOD 8.8 
(87.5)
8.6 
(101.2)
8.9 
(83.1)
11.0 
(69.1)
8.5 
(90.6)
12.0 
(65.8)
15.7 
(66.9) R0
14.3 
(58.7)
15.9 
(67.9)
13.4 
(50.0)
14.0 
(55)
12.9 
(46.5)
n: number of patients. Groups: C = healthy volunteers (all below BMI threshold); R0A = non-neuropathic patients above BMI threshold; R0B = non-neuropathic patients below BMI 
threshold; R1A = neuropathic patients without deformities and above BMI threshold; R1B = neuropathic patients without deformities and below BMI threshold; R2A = neuropathic 
patients with deformities and above BMI threshold; R2B = neuropathic patients with deformities and below BMI threshold; R3A = neuropathic patients with previous ulceration and 
above BMI threshold; R3B = neuropathic patients with previous ulceration and below BMI threshold (IWGDF international consensus, Bus et al., 2016). BMI threshold: 31.3kg/m2). 
Parameters: PP = peak pressure; CA = contact area; MF = maximum force; PTI = pressure-time integral; FTI = force-time integral; CT = contact time. Clinical variables: DNI (Diabetic 
Neuropathy Index, assessed in the Italian study): DNI ranges from 0 to 8; DNI > 2 indicates the presence of PN. VPT (Vibratory Perception Threshold, assessed in the Italian study): 
Biothesiometer-based assessment (Boulton et al., 1986); VPT > 25V indicating a deterioration of vibration perception associated with neuropathy. ABI (ankle brachial index, reported 
in the Italian study): based on ADA indications (Ada, 2003); ABI normal values ≥ 0.9. NSS (Neuropathy signs and symptoms, assessed in the Brazilian study): assessed as in (Young et al., 
1993). NSS values: 3 to 4: mild; 5 to 6: moderate; 7 to 9: severe. YOD: years of disease (i.e. disease duration since medical diagnose). Statistical analysis: significant differences are detailed 
with subscripts (ANOVA (p < 0.05) with post-hoc Holm-Bonferroni correction for multiple comparisons). Measurement from one patient only.
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Table S2
Italian study. PPD main parameters. Mean values, SD (% of mean) and results of ANOVA on clinical subgroups below (B) and above (A) BMI thresh-
old
Variable Foot area Control R1A R1B R2A R2B R3A R3B
PP (kPa) Total (F=1.774; 
p=0.113)
254.2  
(9.1) R1B
279.7  
(21.4) 
212.9  
(15.5) C
279.9  
(22.3) 
257.6  
(30.1) 
280.4  
(21.7) 
257.1  
(23.7) 
Heel (F=1.517; 
p=0.181)
215.1  
(8.5) R1B
209.4  
(24.0) 
179.8  
(16.2) C
205.2  
(20.2) 
181.3  
(25.9) 
203.3  
(31.4) 
211.1  
(19.4) 
Midfoot (F=2.753; 
p=0.016)
92.0  
(9.1) R3A
103.1  
(9.9) 
84.5  
(18.3) R3A
105.1  
(29.9) 
90.7  
(33.8) 
114.4  
(14.6) C,R1B
89.0  
(32.0) 
Forefoot (F=1.818; 
p=0.104)
246.6  
(15.4) 
270.0  
(23.6) 
196.7  
(18.1) 
250.9  
(31.4) 
224.4  
(33.3) 
258.4  
(25.1) 
216.8  
(29.3) 
Toes (F=0.428; 
p=0.859)
144.4  
(19.8) 
126.4  
(47.4) 
130.4  
(26.6) 
144.3  
(45.6) 
147.5  
(61.6) 
154.6  
(54.0) 
122.4  
(63.0
CA 
(%insole)
Total (F=9.304; 
p<0.001)
74.9  
(5.3) R1B,R2B,R3B
71.6  
(6.1) R2B
67.9  
(8.1) C
73.0  
(8.5) R2B,R3B
63.1  
(7.5) C,R1A,R2A
70.7  
(11.6) 
64.6  
(11.6) C,R2A 
Heel (F=4.358; 
p<0.001)
25.7  
(4.7) R2B,R3B
24.6  
(11.4) 
24.2  
(9.3) 
24.8  
(7.9) R3B
23.5  
(7.5) C
24.9  
(9.3) 
22.8  
(6.7) C,R2A
Midfoot (F=6.464; 
p<0.001)
18.8  
(6.2) R1B,R2B,R3B
18.5  
(18.6) 
15.9  
(21.1) C
19.0  
(20.7) R2B
14.4  
(21.9) C,R2A,R3A
19.2  
(17.5) R2B
15.3  
(21.5) C
Forefoot (F=7.608; 
p<0.001)
31.3  
(5.0) R1B,R2A,R2B,R3A,R3B
29.0  
(9.3) 
27.9  
(9.2) C
28.7  
(10.0) C
26.2  
(11.5) C
26.2  
(10.5) C
26.2  
(16.1) C
Toes (F=3.911; 
p=0.002)
10.8  
(18.1) R2A,R2B,R3A,R3B
8.9  
(17.1) 
9.7  
(13.0) 
8.5  
(26.5) C
8.1  
(30.9) C
8.0  
(32.7) C
7.4  
(45.6) C
MF (%N) Total (F=2.180; 
p=0.051)
104.2  
(10.0) 
97.9  
(6.9) 
96.5  
(9.5) 
96.4  
(7.3) 
96.6  
(8.8) 
97.7  
(4.6) 
98.5  
(7.7) 
Heel (F=3.779; 
p=0.002)
65.5  
(13.5) R2A,R3AR
56.3  
(17.5) 
58.4  
(18.4) 
53.8  
(15.3) C
59.3  
(15.0) 
54.2  
(15.8) C
58.7  
(11.8) 
Midfoot (F=2.339; 
p=0.038)
21.7  
(14.5) 
21.3  
(23.5) 
18.5  
(36.6) 
21.0  
(36.9) 
18.0  
(34.8) 
24.5  
(22.4) 
18.2  
(28.9) 
Forefoot (F=5.880; 
p<0.001)
82.9  
(16.7) R1B,R2A,R2B,R3A,R3B
70.5  
(14.7) 
63.9  
(12.8) C
62.3  
(24.9) C
65.6  
(22.2) C
61.1  
(23.6) C
58.1  
(30.7) C
Toes (F=1.677; 
p=0.135)
15.5  
(25.7) R1A
9.5  
(40.5) C
15.1  
(28.2) 
11.8  
(57.0) 
14.0  
(62.6) 
11.8  
(50.9) 
11.3  
(64.1) 
PTI (kPa*s) Total (F=1.031; 
p=0.410)
139.2  
(10) 
164.4  
(22.4) 
139.2  
(29.6) 
160.2  
(38.9) 
145.7  
(22.6) 
149.4  
(20.5) 
159.9  
(17.6) 
Heel (F=1.164; 
p=0.332)
82.8  
(17.9) 
93.2  
(33.9) 
84.6  
(38.4) 
95.3  
(53.7) 
81.6  
(24.2) 
83.2  
(22.0) 
104.7  
(31.0) 
Midfoot (F=1.284; 
p=0.272)
45.6  
(15.1) R1A
58.5  
(18.0) C
46.4  
(41.3) 
62.6  
(78.8) 
48.0  
(37.0) 
57.6  
(24.5) 
46.3  
(30.5) 
Forefoot (F=1.640; 
p=0.144)
86.6  
(10.5) R1A,R3A
121.4  
(20.4) C
94.9  
(32.4) 
114.9  
(52.1) 
102.0  
(30.8) 
108.9  
(24.6) C
104.2  
(32.1) 
Toes (F=0.710; 
p=0.642)
35.6  
(17.0) 
34.8  
(39.1) 
47.1  
(40.8) 
44.4  
(53.0) 
40.8  
(54.3) 
45.8  
(64.2) 
40.1  
(56.1) 
FTI (%N*s) Total (F=0.553; 
p=0.766)
67.5  
(15.0) 
69.1  
(12.4) 
68.5  
(25.6) 
65.1  
(35.2) 
67.7  
(16.2) 
60.9  
(12.4) 
68.3  
(14.6) 
Heel (F=1.355; 
p=0.241)
24.7  
(24.4) 
23.4  
(24.7) 
26.6  
(34.7) 
23.4  
(44.9) 
26.3  
(30.1) 
21.4  
(15.8) 
28.7  
(31.0) 
Midfoot (F=0.978; 
p=0.444)
8.7  
(21.3) 
10.7  
(32.8) 
8.8  
(48.5) 
10.7  
(71.0) 
8.7  
(48.3) 
11.0  
(28.7) 
8.4  
(36.6) 
Forefoot (F=1.292; 
p=0.268)
30.6  
(16.3) 
32.4  
(11.5) R3A
28.9  
(24.7) 
27.7  
(35.0) 
29.0  
(21.7) 
25.2  
(20.1) R1A
27.8  
(34.8) 
Toes (F=0.753; 
p=0.609)
3.6  
(27.0) 
2.5  
(27.0) 
4.3  
(46.8) 
3.3  
(32.8) 
3.8  
(64.6) 
3.3  
(63.5) 
3.4  
(66.1) 
CT (ms) Stance (ms) 
(F=0.933; p=0.475)
822.5  
(7.1) R1A
934.3  
(12.4) C
985.4  
(29.7) 
936.0  
(46.5) 
946.5  
(21.9) 
834.7  
(14.0) 
945.4  
(19.3) 
CT 
(%stance)
Heel (F=5.111; 
p<0.001)
72.7  
(8.6) R1A,R2A,R2B,R3A,R3B
83.2  
(11.4) C
77.7  
(11.9) 
82.7  
(10.6) C
82.6  
(7.4) C
82.9  
(6.5) C
83.8  
(9.1) C
(Continues)
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Table S2
(Continued)
Variable Foot area Control R1A R1B R2A R2B R3A R3B
Midfoot (F=2.689; 
p=0.019)
83.2  
(5.2) 
85.2  
(4.1) 
79.1  
(9.8) 
83.1  
(7.5) 
79.2  
(10.3) 
84.6  
(4.9) 
77.9  
(11.5) 
Forefoot 
(F=14.261; 
p<0.001)
91.8  
(2.7) R1A,R1B,R2A,R2B,R3A,R3B
97.4  
(1.5) C
95.3  
(2.3) C
96.7  
(2.5) C
96.2  
(2.2) C
97.1  
(2.4) C
97.6  
(2.3) C
Toes (F=0.508; 
p=0.801)
67.0  
(16.1) 
64.2 
(20.6) 
72.3  
(17.1) 
69.7  
(26.6) 
61.9  
(30.1) 
66.4  
(36.9) 
66.1  
(25.1) 
n: number of patients. Groups: C = healthy volunteers (all below BMI threshold); R1A = neuropathic patients without deformities and above BMI threshold; R1B = neuropathic patients 
without deformities and below BMI threshold; R2A = neuropathic patients with deformities and above BMI threshold; R2B= neuropathic patients with deformities and below BMI 
threshold; R3A = neuropathic patients with previous ulceration and above BMI threshold; R3B = neuropathic patients with previous ulceration and below BMI threshold (IWGDF 
international consensus, Bus et al., 2016). BMI threshold: 31.3kg/m2). Parameters: PP = peak pressure; CA = contact area; MF = maximum force; PTI = pressure-time integral; FTI = 
force-time integral; CT = contact time. Statistical analysis: significant differences are detailed with subscripts (ANOVA (p < 0.05) with post-hoc Holm-Bonferroni correction for multiple 
comparisons).
Table S3
Brazilian study. PPD main parameters. Mean values, SD (% of mean) and results of ANOVA on clinical subgroups below (B) and above (A) BMI 
threshold
Variable Foot area R0A R0B R1A R1B R2A R2B R3A R3B
PP (kPa) Total 360.1  
(27.8) 
327.3  
(14.7) a
397.5  
(22.3) 
366.8  
(16.8) 
315.9  
(8.5) 
344.9  
(20.7) 
399.1  
(21.7) 
406.1  
(16.5) a
F = 2.985; P = 0.0062 
R0B < R3B
Heel 298.4  
(31.5) 
278.8  
(17.8) 
291.2  
(15.2) 
292.8  
(17.7) 
245.6  
(13.4) 
285.1  
(22.0) 
300.5  
(31.2) 
316.3  
(20.0) 
F = 0.710; P = 0.6638
Midfoot 124.5  
(32.5) 
119.1  
(42.4) 
149.4  
(21.0) 
141.0  
(30.0) 
128.9  
(10.9) 
130.4  
(53.2) 
115.0  
(25.9) 
174.8  
(58.5) 
F = 1.11; P = 0.3589
Forefoot 347.6  
(28.0) 
300.7  
(18.9) a,b
365.1  
(15.8) 
351.5  
(18.8) 
310.7  
(7.5) 
324.5  
(22.7) 
390.2  
(22.1) b
393.9  
(16.9) a
F = 3.836; P = 0.0008 
R0B < R3B 
R0B < R3A
Toes 185.9  
(42.1) 
157.8  
(48.5) 
218.3  
(57.9) 
145.9  
(48.6) 
89.9  
(68.3) 
139.4  
(48.1) 
146.8  
(32.5) 
134.4  
(50.7) 
F = 1.386; P = 0.2168
CA 
(%insole)
Total 87.3  
(8.2) a
82.6  
(10.5) 
83.8  
(13.4) 
80.9  
(7.2) 
87.3  
(1.5) 
78.0  
(10.8) a
81.9  
(10.1) 
77.1  
(7.5) 
F = 2.836 ; P = 0.0009 
R0A > R2B
Heel 39.65  
(12.6) 
38.7  
(12.4) 
42.5  
(12.0) 
39.7  
(17.6) 
43.1 
(10.4) a,b
37.4  
(15.5) a
44.0  
(11.6) 
41.7  
(13.4) b
F = 2.347; P = 0.0275 
R2B < R2A,  
R2A > R3B
Midfoot 24.94  
(23.7) 
23.0  
(27.4) 
30.0  
(15.7) a
25.1  
(19.5) 
27.8  
(22.7) 
20.9  
(27.2) a
25.4  
(17.7) 
25.1  
(31.1) 
F = 2.347; P = 0.0275  
R1A < R2B
Forefoot 45.52  
(7.2) 
43.0  
(7.7) 
44.3  
(8.8) 
42.3  
(9.0) 
44.9  
(6.9) 
43.0  
(8.4) 
44.1  
(8.2) 
43.9  
(9.1) 
F = 1.867; P = 0.0803
Toes 13.26  
(23.4) 
12.6  
(30.2) 
13.4  
(21.7) 
12.1  
(29.7) 
10.3  
(49.7) 
11.1  
(22.5) 
13.2  
(28.8) 
13.8  
(13.0) 
F = 1.238; P = 0.271
MF (%N) Total 96.7  
(11.6) 
97.9  
(11.0) 
89.1  
(9.5) 
94.9  
(8.9) 
85.8  
(10.7) 
95.7  
(8.7) 
90.9  
(12.5) 
94.9  
(12.4) 
F = 1.535; P = 0.1614
Heel 63.0  
(17.9) 
69.6  
(14.2) a
57.9  
(16.1) a
65.8  
(14.6) 
58.8  
(16.0) 
64.8  
(12.6) 
62.2  
(17.2) 
65.0  
(15.7) 
F = 2.146; P = 0.0434 
R0B > R1A
Midfoot 17.1  
(39.7) 
17.1  
(45.0) 
20.0  
(32.0) 
18.7  
(38.6) 
19.9  
(13.6) 
15.4  
(40.2) 
13.5  
(34.0) 
21.5  
(73.1) 
F = 1.064; P = 0.3906
Forefoot 76.6  
(12.3) 
76.0  
(13.6) 
69.2  
(11.9) 
74.7  
(11.6) 
72.1  
(14.0) 
76.1  
(13.7) 
73.9  
(18.9) 
72.1  
(8.9) 
F = 0.522; P = 0.8163
Toes 11.6  
(45.8) 
11.8  
(55.0) 
10.4  
(50.1) 
8.7  
(40.0) 
4.9  
(83.5) 
8.9  
(40.4) 
8.7  
(45.0) 
8.5  
(42.4) 
F = 1.723; P = 0.1092
PTI (kPa*s) Total 150.2  
(19.8) 
145.3  
(32.7) 
161.2  
(21.3) 
147.0  
(18.6) 
141.6  
(14.1) 
147.7  
(19.2) 
168.6  
(16.8) 
168.2  
(17.6) 
F = 0.785; P = 0.6013
Heel 75.2  
(20.9) 
82.6  
(43.5) 
81.7  
(15.2) 
78.5  
(25.4) 
79.2  
(7.4) 
75.1  
(22.6) 
91.7  
(39.4) 
79.0  
(19.4) 
F = 0.555; P = 0.7911
Midfoot 43.8  
(37.0) 
41.5  
(54.0) 
50.9  
(16.3) 
43.6  
(33.5) 
48.0  
(22.1) 
42.5  
(52.7) 
41.2  
(30.1) 
54.8  
(52.8) 
F = 0.438; P = 0.8769
(Continues)
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Table S3
(Continued)
Variable Foot area R0A R0B R1A R1B R2A R2B R3A R3B
Forefoot 104.1  
(26.1) 
94.2  
(38.4) 
104.4  
(17.1) 
99.1  
(20.4) 
95.7  
(17.7) 
102.9  
(23.2) 
118.2  
(22.6) 
119.6  
(26.8) 
F = 1.328; P = 0.2423
Toes 40.9  
(52.8) 
34.7  
(78.9) 
50.4  
(95.8) 
29.9  
(47.8) 
20.5  
(90.7) 
31.02  
(49.3) 
33.3  
(44.1) 
29.8  
(39.6) 
F = 0.773; P = 0.6113
FTI (%N*s) Total 46.4  
(8.6) 
49.0  
(40.8) 
43.2  
(9.7) 
44.8  
(10.5) 
47.0  
(11.5) 
46.3  
(8.4) 
45.5  
(8.4) 
45.0  
(12.7) 
F = 0.447; P = 0.8706
Heel 15.6  
(16.0) 
18.2  
(44.0) 
15.0  
(14.0) 
16.6  
(21.0) 
18.1  
(11.6) 
16.6  
(19.9) 
17.1  
(19.9) 
15.9  
(17.6) 
F = 0.7610; P = 0.6209
Midfoot 5.5  
(49.4) 
5.4  
(60.7) 
6.5  
(27.9) 
5.6  
(46.7) 
6.3  
(27.1) 
4.6  
(49.8) 
4.6  
(51.7) 
6.3  
(73.4) 
F = 0.595; P = 0.7587
Forefoot 22.9  
(17.0) 
23.0  
(40.9) 
19.7  
(15.2) 
20.9  
(13.4) 
21.4  
(15.9) 
23.2  
(16.0) 
22.1  
(13.6) 
21.1  
(24.2) 
F = 0.5077; P = 0.8274
Toes 2.4  
(54.9) 
2.4  
(83.0) 
2.1  
(57.1) 
1.7  
(46.5) 
1.2  
(101.7) 
1.9  
(48.4) 
1.7  
(47.9) 
1.7  
(40.5) 
F = 0.873; P = 0.5293
CT (ms) Total 659.4  
(12.5) 
709.3  
(52.9) 
669.4  
(7.2) 
661.3  
(9.0) 
697.3  
(7.3) 
655.8  
(7.5) 
676.4  
(6.1) 
670.3  
(10.3) 
F = 0.2014; P = 0.09846
CT 
(%stance)
Heel 82.4  
(14.4) 
83.6  
(14.5) 
90.6  
(9.3) 
91.0  
(10.6) 
91.9  
(8.1) 
85.5  
(11.3) 
89.3  
(7.3) 
90.3  
(8.0) 
F = 1.785; P = 0.0958
Midfoot 83.1  
(9.0) 
83.1  
(16.0) 
90.6  
(6.4) 
85.2  
(11.5) 
90.2  
(10.1) 
83.0  
(13.3) 
84.6  
(8.0) 
87.5  
(13.1) 
F = 0.577; P = 0.7735
Forefoot 96.4  
(3.1) 
95.6  
(3.9) 
96.9  
(2.9) 
96.9  
(2.2) 
97.1  
(2.8) 
96.6  
(2.6) 
95.1  
(6.9) 
97.6  
(2.7) 
F = 0.67; P = 0.6936
Toes 67.4  
(27.3) 
67.3  
(30.3) 
73.5  
(24.9) 
72.1  
(24.3) 
63.1  
(41.4) 
70.8  
(20.8) 
72.0  
(23.8) 
81.2  
(14.8) 
F = 0.932; P = 0.4841
n: number of patients. Groups: R0A = non-neuropathic patients above BMI threshold; R0B = non-neuropathic patients below BMI threshold; R1A = neuropathic patients without 
deformities and above BMI threshold; R1B = neuropathic patients without deformities and below BMI threshold; R2A = neuropathic patients with deformities and above BMI threshold; 
R2B = neuropathic patients with deformities and below BMI threshold; R3A = neuropathic patients with previous ulceration and above BMI threshold; R3B = neuropathic patients with 
previous ulceration and below BMI threshold (IWGDF international consensus (Bus et al., 2016). BMI threshold: 31.3kg/m2). Parameters: PP = peak pressure; CA = contact area; MF = 
maximum force; PTI = pressure-time integral; FTI=force-time integral; CT = contact time. Statistical analysis: significant differences are detailed with subscripts (ANOVA (p < 0.05) with 
post-hoc Holm-Bonferroni correction for multiple comparisons): x represents the condition different from the others; differences between groups are represented by a couple of 
letters a, b, c. Measure from one patient only.
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Figure S1
Main results of the BMI-based investigation within both the Italian study (left side) and the Brazilian study (right side): mean values ± 
SD of CT, PP, and PTI under the heel (first and third columns) and the forefoot (second and fourth columns) for controls (C, Italian study, 
black markers and lines) or non-neuropathic group (R0, Brazilian study, grey markers and lines) and all neuropathic groups, both above 
(A, red markers and lines) and below (B, blue markers and lines) the BMI threshold.
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Table S4 
Results of the 2-way-ANOVA (p < 0.05) conducted on PPD parameters of the two studies (Italian and Brazilian) associated with groups R1, R2, and 
R3
Variable p value
Factor A Factor B Interaction Interpretation of study values
PP (kPa) Total < 0.001 0.086 0.037 Italian < Brazilian. Interaction
Heel < 0.001 0.170 0.789 Italian < Brazilian
Midfoot < 0.001 0.636 0.622 Italian < Brazilian
Forefoot < 0.001 0.059 0.036 Italian < Brazilian. Interaction
Toes 0.457 0.891 0.267 comparable
CA (%insole) Total < 0.001 0.276 0.850 Italian > Brazilian
Heel < 0.001 0.719 0.439 Italian < Brazilian
Midfoot 0.133 0.154 0.413 comparable
Forefoot 0.006 0.022 0.284 Italian < Brazilian
Toes 0.495 0.136 0.110 comparable
MF (%N) Total 0.009 0.991 0.585 Italian > Brazilian
Heel < 0.001 0.979 0.939 Italian < Brazilian
Midfoot 0.022 0.371 0.610 Italian > Brazilian
Forefoot < 0.001 0.248 0.303 Italian < Brazilian
Toes < 0.001 0.853 0.741 Italian > Brazilian
PTI (kPa*s) Total 0.816 0.268 0.381 comparable
Heel 0.024 0.400 0.923 Italian > Brazilian
Midfoot 0.051 0.995 0.634 comparable 
Forefoot 0.835 0.480 0.244 comparable
Toes 0.008 0.952 0.661 Italian > Brazilian
FTI (%N*s) Total < 0.001 0.778 0.517 Italian > Brazilian
Heel < 0.001 0.969 0.938 Italian > Brazilian
Midfoot < 0.001 0.792 0.810 Italian > Brazilian
Forefoot < 0.001 0.367 0.069 Italian > Brazilian
Toes < 0.001 0.918 0.943 Italian > Brazilian
CT (ms) Total < 0.001 0.826 0.662 Italian > Brazilian
CT (%stance) Heel < 0.001 0.390 0.124 Italian < Brazilian
Midfoot 0.009 0.512 0.741 Italian < Brazilian
Forefoot 0.796 0.875 0.421 comparable
Toes 0.032 0.609 0.624 Italian < Brazilian
Groups: R1 = neuropathic patients without deformities; R2 = neuropathic patients with deformities or vasculopathy; R3 = neuropathic patients with previous ulceration (IWGDF 
international consensus, Bus et al., 2016). Parameters: PP = peak pressure; CA = contact area; MF = maximum force; PTI = pressure-time integral; FTI = force-time integral; CT = contact 
time. Statistical analysis: two-way ANOVA (p < 0.05) with multiple comparisons (Holm-Bonferroni correction). ANOVA Factor A: study (two levels: Italian, Brazilian); ANOVA Factor B: 
groups (three levels: R1, R2, R3). Statistically significant p are written in red.
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Table S5 
Results of the 2-way-ANOVA (p<0.05) conducted on PPD parameters of both the Italian and the Brazilian study associated with only neuropathic 
groups of each study i.e. R1A , R1B , R2A , R2B , R3A , R3B (ANOVA Factor A: study, Italian, Brazilian; ANOVA Factor B: groups, R1A, R1B, R2A, R2B, R3A, R3B)
Variable Factor A Factor B Interaction Interpretation
PP (kPa) Total F=6.887; P=0.010 F=0.117; P=0.989 F=0.521; P=0.760 Italian < Brazilian
Heel F=9.467; P=0.003 F=0.210; P=0.958 F=-0.018; P<0.001 Italian < Brazilian. Interaction. All Italian Rn < Brazilian 
RnB (also, Italian RnB < Brazilian R1A and R3A)
Midfoot F=6.691; P=0.011 F=0.105; P=0.991 F=0.831; P=0.530 Italian < Brazilian
Forefoot F=9.162; P=0.003 F=0.210; P=0.958 F=0.496; P=0.779 Italian < Brazilian
Toes F=0.176; P=0.675 F=0.308; P=0.908 F=1.430; P=0.217 Italian and Brazilian comparable
CA (%insole) Total F=1.672; P=0.198 F=0.079; P=0.995 F=0.134; P=0.984 Italian and Brazilian comparable
Heel F=0.686; P=0.409 F=0.052; P=0.998 F=0.135; P=0.984 Italian and Brazilian comparable 
Midfoot F=0.199; P=0.656 F=0.558; P=0.732 F=0.009; P=1.000 Italian and Brazilian comparable
Forefoot F=0.329; P=0.567 F=0.066; P=0.997 F=0.033; P=0.999 Italian and Brazilian comparable 
Toes F=0.043; P=0.836 F=0.129; P=0.986 F=0.265; P=0.931 Italian and Brazilian comparable
MF (%N) Total F=0.097; P=0.756 F=0.006; P=1.000 F=0.075; P=0.996 Italian and Brazilian comparable
Heel F=1.078; P=0.301 F=0.187; P=0.967 F=-0.155; P<0.001 Italian and Brazilian comparable. Interaction.
Midfoot F=1.304; P=0.255 F=0.350; P=0.882 F=0.425; P=0.831 Italian and Brazilian comparable
Forefoot F=1.824; P=0.179 F=0.168; P=0.974 F=-0.147; P<0.001 Italian and Brazilian comparable. Interaction.
Toes F=6.094; P=0.015 F=0.059; P=0.998 F=1.622; P=0.158 Italian > Brazilian
PTI (kPa*s) Total F=0.002; P=0.962 F=0.122; P=0.987 F=0.105; P=0.991 Italian and Brazilian comparable
Heel F=1.243; P=0.267 F=0.310; P=0.906 F=-0.068; P<0.001 Italian and Brazilian comparable. Interaction.
Midfoot F=1.790; P=0.183 F=0.646; P=0.665 F=-0.196; P<0.001 Italian and Brazilian comparable. Interaction.
Forefoot F=0.053; P=0.818 F=0.170; P=0.973 F=0.179; P=0.970 Italian and Brazilian comparable
Toes F=3.772; P=0.054 F=0.284; P=0.921 F=1.147; P=0.338 Italian and Brazilian comparable
FTI (%N*s) Total F=9.642; P=0.002 F=0.253; P=0.938 F=-0.113; P<0.001 Italian > Brazilian. Interaction
Heel F=10.725; P=0.001 F=0.382; P=0.861 F=0.016; P=1.000 Italian > Brazilian
Midfoot F=17.855; P<0.001 F=1.467; P=0.204 F=-1.354; P<0.001 Italian > Brazilian. Interaction
Forefoot F=4.639; P=0.033 F=0.184; P=0.968 F=0.252; P=0.938 Italian > Brazilian
Toes F=19.789; P<0.001 F=0.302; P=0.911 F=1.179; P=0.323 Italian > Brazilian
CT (ms) Total F=7.317; P=0.008 F=0.243; P=0.943 F=-0.214; P<0.001 Italian > Brazilian. Interaction.
CT (%stance) Heel F=0.378; P=0.540 F=0.010; P=1.000 F=0.059; P=0.998 Italian and Brazilian comparable
Midfoot F=0.145; P=0.704 F=0.035; P=0.999 F=0.062; P=0.997 Italian and Brazilian comparable
Forefoot F=0.000; P=0.995 F=0.001; P=1.000 F=0.002; P=1.000 Italian and Brazilian comparable
Toes F=0.480; P=0.489 F=0.035; P=0.999 F=0.167; P=0.974 Italian and Brazilian comparable
Groups: R1A = neuropathic patients without deformities and above BMI threshold; R1B = neuropathic patients without deformities and below BMI threshold; R2A = neuropathic patients 
with deformities and above BMI threshold; R2B = neuropathic patients with deformities and below BMI threshold; R3A = neuropathic patients with previous ulceration and above BMI 
threshold; R3B = neuropathic patients with previous ulceration and below BMI threshold; (IWGDF international consensus, Bus et al., 2016). BMI threshold: 31.3kg/m2). Parameters: PP = 
peak pressure; CA = contact area; MF = maximum force; PTI = pressure-time integral; FTI = force-time integral; CT = contact time.
